FRANCES GREEN: Open Payments
NPI 1992347272 · HUNTSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$690 in 25 payments from 8 companies in 2025. Trend: 2023 $824 · 2024 $605 · 2025 $690
Food & beverage: $690
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 10 | $273 |
| UCB, Inc. | 1 | $125 |
| Corcept Therapeutics | 5 | $116 |
| ABBVIE INC. | 4 | $92 |
| Amgen Inc. | 2 | $27 |
| Otsuka America Pharmaceutical, Inc. | 1 | $27 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
| Axsome Therapeutics, Inc. | 1 | $10 |
Products named: OCTAGAM IMMUNE GLOBULIN (HUMAN), Bimzelx, Korlym, VRAYLAR, XELJANZ, EVENITY, REXULTI, BREZTRI.
Industry payments across AL — which companies pay providers there.
